InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.